Mobius Therapeutics, a St. Louis-based developer of systems for the surgical treatment of glaucoma, has raised $3.5 million in first-round funding, according to a regulatory filing. No investor information was disclosed. www.mobiustherapeutics
Mobius Therapeutics Raises First Round
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.